Liu Y, Zhang Z, Zhou L, Lin T, Zhang R, Li M
BMC Infect Dis. 2025; 25(1):141.
PMID: 39885384
PMC: 11783785.
DOI: 10.1186/s12879-025-10560-y.
Zhang K, Zhao G, Liu Y, Huang Y, Long J, Li N
BMC Med Imaging. 2024; 24(1):264.
PMID: 39375609
PMC: 11457327.
DOI: 10.1186/s12880-024-01442-x.
Song L, Qiu L, Wang G, Zou W, Zhang S, Sai L
Sci Rep. 2024; 14(1):20364.
PMID: 39223294
PMC: 11369242.
DOI: 10.1038/s41598-024-71455-7.
Bay P, Audureau E, Preau S, Favory R, Guigon A, Heming N
Ann Intensive Care. 2024; 14(1):65.
PMID: 38658426
PMC: 11043290.
DOI: 10.1186/s13613-024-01296-0.
Zhou X, Wu X, Chen Z, Cui X, Cai Y, Liu Y
Front Cell Infect Microbiol. 2023; 13:1287496.
PMID: 38076456
PMC: 10703051.
DOI: 10.3389/fcimb.2023.1287496.
Secondary infections in critically ill patients with COVID-19 receiving steroid therapy.
Pearce A, Zawaydeh Q, McGuire W, Husain A, Ayoub C, Sweeney D
Sci Prog. 2023; 106(4):368504231207209.
PMID: 37899703
PMC: 10617276.
DOI: 10.1177/00368504231207209.
COVID-19-associated pulmonary aspergillosis in patients with severe SARS-CoV-2 infection: A single-center observational study from Greece.
Ouranos K, Tsakiri K, Massa E, Dourliou V, Mouratidou C, Soundoulounaki S
Ann Thorac Med. 2023; 18(3):116-123.
PMID: 37663880
PMC: 10473063.
DOI: 10.4103/atm.atm_14_23.
COVID-19-Associated Pulmonary Aspergillosis (CAPA).
Dimopoulos G, Almyroudi M, Myrianthefs P, Rello J
J Intensive Med. 2023; 1(2):71-80.
PMID: 36785564
PMC: 8346330.
DOI: 10.1016/j.jointm.2021.07.001.
Severe Recurrent COVID-Associated Pulmonary Aspergillosis: A Challenging Case.
Vetrugno L, Anzellotti G, Frontera R, Parinisi Z, Sessa B, Deana C
Healthcare (Basel). 2022; 10(12).
PMID: 36554008
PMC: 9778552.
DOI: 10.3390/healthcare10122483.
Clinical and Microbiological Characteristics of Aspergillosis at a Chinese Tertiary Teaching Hospital.
Xiao C, Qiao D, Xiong L, Tian W, Wang D, Deng S
Infect Drug Resist. 2022; 15:7249-7257.
PMID: 36533254
PMC: 9753761.
DOI: 10.2147/IDR.S391069.
Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
Serin I, Baltali S, Cinli T, Goze H, Demir B, Yokus O
BMC Infect Dis. 2022; 22(1):822.
PMID: 36348480
PMC: 9644000.
DOI: 10.1186/s12879-022-07828-y.
Biofilms possibly harbor occult SARS-CoV-2 may explain lung cavity, re-positive and long-term positive results.
He D, Fu C, Ning M, Hu X, Li S, Chen Y
Front Cell Infect Microbiol. 2022; 12:971933.
PMID: 36250053
PMC: 9554432.
DOI: 10.3389/fcimb.2022.971933.
Comparative risk assessment of COVID-19 associated mucormycosis and aspergillosis: A systematic review.
Baral P, Aziz M, Islam M
Health Sci Rep. 2022; 5(5):e789.
PMID: 36000078
PMC: 9387898.
DOI: 10.1002/hsr2.789.
Exploring SARS-CoV2 host-pathogen interactions and associated fungal infections cross-talk: Screening of targets and understanding pathogenesis.
Khan A, Jain S, Rai M, Panda S
Comput Struct Biotechnol J. 2022; 20:4351-4359.
PMID: 35965662
PMC: 9364728.
DOI: 10.1016/j.csbj.2022.08.013.
COVID-19-associated pulmonary aspergillosis is associated with increased in-hospital mortality and prolonged SARS-CoV-2 viral shedding.
Huang J, Shen H, Sun C, Chen W, Chen Y, Feng J
J Formos Med Assoc. 2022; 121(12):2617-2625.
PMID: 35953342
PMC: 9359693.
DOI: 10.1016/j.jfma.2022.07.006.
The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.
Akhtar N, Wani A, Tripathi S, Prakash A, Mannan M
Curr Res Biotechnol. 2022; 4:337-349.
PMID: 35942223
PMC: 9347179.
DOI: 10.1016/j.crbiot.2022.08.001.
CT findings of COVID-19-associated pulmonary aspergillosis: a systematic review and individual patient data analysis.
Hong W, White P, Backx M, Gangneux J, Reizine F, Koehler P
Clin Imaging. 2022; 90:11-18.
PMID: 35908455
PMC: 9425042.
DOI: 10.1016/j.clinimag.2022.07.003.
Fungal Infection in Co-infected Patients With COVID-19: An Overview of Case Reports/Case Series and Systematic Review.
Seyedjavadi S, Bagheri P, Nasiri M, Razzaghi-Abyaneh M, Goudarzi M
Front Microbiol. 2022; 13:888452.
PMID: 35875562
PMC: 9298665.
DOI: 10.3389/fmicb.2022.888452.
Overview of COVID-19-Associated Invasive Fungal Infection.
Shishido A, Mathew M, Baddley J
Curr Fungal Infect Rep. 2022; 16(3):87-97.
PMID: 35846240
PMC: 9274633.
DOI: 10.1007/s12281-022-00434-0.
Tendency in Pulmonary Aspergillosis Investigation during the COVID-19 Era: What Is Changing?.
Caggiano G, Apollonio F, Consiglio M, Gasparre V, Trerotoli P, Diella G
Int J Environ Res Public Health. 2022; 19(12).
PMID: 35742328
PMC: 9222563.
DOI: 10.3390/ijerph19127079.
